首頁 > 市場調查報告書 > 醫療設備

感測器拋棄式

市場調查報告書

商品編碼

1643892

全球一次性醫療感測器市場 - 2025-2033

Global Disposable Medical Sensors Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 234 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球一次性醫療感測器市場規模達到117億美元，預計2033年將達到370億美元，2025-2033年預測期間複合年成長率為13.3%。

一次性醫療感測器是緊湊、輕巧且經濟高效的設備，用於醫療保健環境中，用於檢測和測量身體的生理變化。它們測量溫度、心率、呼吸頻率、血糖水平和氧飽和度等參數。常見應用包括患者監測、糖尿病管理和檢測感染。它們的一次性特性降低了交叉污染風險，提高了病患安全，並簡化了設備處理和維護。

市場動態：

驅動程式和限制

不斷進步的技術

技術進步對全球一次性醫療感測器市場產生了重大影響，導致了更小、更有效率的感測器的開發，這些感測器可以整合到穿戴式裝置、貼片和可植入系統中。這些感測器能夠持續監測患者的生命徵象、血糖水平和心臟活動，從而減少就診次數並促進主動的醫療保健管理。材料科學的進步使得感測器具有更高的生物相容性、耐用性和靈敏度，確保最大限度地減少不適並改善臨床結果。藍牙和 NFC 等無線通訊技術增強了一次性感測器的可用性，實現了向智慧型手機、雲端系統和醫療設備的無縫資料傳輸，這對於遠端患者監護和遠距醫療至關重要。

例如，2024 年 1 月，美敦力 (Medtronic) 的 MiniMed 780G 系統與 Simplera Sync（一款一次性一體式連續血糖監測儀）獲得了 CE 標誌批准。該設備無需指尖採血或過度粘貼，可提供改進的用戶體驗，尺寸只有以前的美敦力感測器的一半。

有限的監管批准和標準

全球一次性醫療感測器市場受到有限的監管批准和標準的阻礙。醫療器材的核准流程因地區而異，為製造商創造了一個複雜的環境。缺乏統一的全球標準可能會導致產品開發的延遲、成本的增加以及新感測器的上市時間。監管政策的變化或不一致也會擾亂市場，使製造商難以維持一致的產品供應。因此，一次性醫療感測器的引入減緩了整個行業的成長。

Honeywell International, Inc
GE Healthcare
Koninklijke Philips NV
Sensirion AG
Analog Devices, Inc
Gentag Inc
Smiths Medical
ACE Medical Devices
Abbott Laboratories
Similar data will be provided for each market player.
根浦醫療
- 管道產品說明
- 產品關鍵績效指標 (KPI)
- 主要活動
- 市場進入時間表
- 產品滲透率
- 銷售估算與預測
戴蒙泰克公司
生物感測器
葡萄糖莫迪
知識實驗室
將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄

Product Code: MD1681

The global disposable medical sensors market reached US$ 11.7 billion in 2024 and is expected to reach US$ 37.0 billion by 2033, growing at a CAGR of 13.3% during the forecast period 2025-2033.

Disposable medical sensors are compact, lightweight, and cost-effective devices used in healthcare settings to detect and measure physiological changes in the body. They measure parameters like temperature, heart rate, respiratory rate, glucose levels, and oxygen saturation. Common applications include patient monitoring, diabetes management, and detecting infections. Their disposable nature reduces cross-contamination risk, enhances patient safety, and simplifies device handling and maintenance.

Market Dynamics: Drivers & Restraints

Increasing Technological Advancements

Technological advancements have significantly impacted the global disposable medical sensors market, leading to the development of smaller, more efficient sensors that can be integrated into wearable devices, patches, and implantable systems. These sensors enable continuous patient monitoring for vital signs, glucose levels, and cardiac activity, reducing hospital visits and promoting proactive healthcare management. Materials science advancements have led to sensors with higher biocompatibility, durability, and sensitivity, ensuring minimal discomfort and improved clinical outcomes. Wireless communication technologies like Bluetooth and NFC have enhanced the usability of disposable sensors, enabling seamless data transmission to smartphones, cloud systems, and medical devices, crucial for remote patient monitoring and telemedicine.

For instance, in January 2024, Medtronic has received CE Mark approval for its MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor. This device requires no fingersticks or overtape, offers an improved user experience, and is half the size of previous Medtronic sensors.

Limited Regulatory Approvals and Standards

The global disposable medical sensors market is hindered by limited regulatory approvals and standards. The approval process for medical devices varies across regions, creating a complex landscape for manufacturers to navigate. This lack of uniform global standards can lead to delays in product development, increased costs, and time-to-market for new sensors. Changes or inconsistencies in regulatory policies can also disrupt the market, making it difficult for manufacturers to maintain consistent product offerings. As a result, the introduction of disposable medical sensors slows overall industry growth.

Segment Analysis

The global disposable medical sensors market is segmented based on product type, sensor type, application, end user and region.

Product Type:

Biosensors segment is expected to dominate the Disposable Medical Sensors market share

The biosensors segment holds a major portion of the disposable medical sensors market share and is expected to continue to hold a significant portion of the disposable medical sensors market share during the forecast period.

Biosensors are vital in the global disposable medical sensors market, providing real-time monitoring of biological markers essential for patient care and disease management. These sensors detect biochemical reactions, allowing continuous monitoring of critical parameters like glucose levels, blood oxygen saturation, and lactate levels. Biosensors are cost-effective, easy to use, and disposable after a single use, reducing infection risk and enhancing patient safety. The growing prevalence of chronic diseases like diabetes and cardiovascular disorders drives demand for biosensors in clinical and home healthcare settings. As biosensor technology advances, they are expected to play a more integral role in personalizing healthcare and improving patient outcomes.

For instance, in January 2023, a new biosensor chip developed by NIST, Brown University, and CEA-Leti identifies biomarkers by measuring binding between DNA strands and the device. This modular design lowers costs by making it easier to mass produce and allowing the most expensive components to be reused. This could increase accessibility to high-quality diagnostics, as traditional methods can be laborious, expensive, or limited in their findings.

Application:-

Patient Monitoring segment is the fastest-growing segment in Disposable Medical Sensors market share

The patient monitoring segment is the fastest-growing segment in the disposable medical sensors market share and is expected to hold the market share over the forecast period.

Patient monitoring is among the fastest-growing sections of the market, and disposable sensors are fast becoming standard with regard to patient monitoring. In both the rural and urban areas of developing countries, there has emerged a growing demand for in-home patient monitoring. Such increasing demand has permitted companies to rely heavily on medical device sensors for patient monitoring purposes.Remote patient monitoring helps doctors and hospitals maintain a watch on patients outside the traditional setting of the clinic, where technology can help provide 24/7 data between patients and physicians.

For instance, in January 2023, Blue Spark Technologies is launching a unique multi-sensor remote patient monitoring platform, VitalTraq, which includes a contactless vital sign measurement sensor, Remote Photoplethysmography (rPPG). This allows patients, clinicians, and researchers to collect digital measurements of vital signs like Heart Rate, Heart Rate Variability, Blood Pressure, and Respiratory Rate in a single contactless patient experience.

Geographical Analysis

North America is expected to hold a significant position in the Disposable Medical Sensors market share

North America holds a substantial position in the disposable medical sensors market and is expected to hold most of the market share due to strong healthcare infrastructure, rising healthcare spending, and advanced technology. The region's emphasis on improving patient outcomes and optimizing healthcare delivery encourages the use of disposable medical sensors in hospitals, clinics, and home-care settings. The rising prevalence of chronic diseases like diabetes and cardiovascular conditions demands continuous monitoring, which disposable medical sensors can efficiently address. Key market players and significant sensor innovation investments further accelerate market growth.

For instance, according to Centers for Medicare & Medicaid Services in 2023, health care spending grew 7.5% to US$ 4.9 trillion, reaching US$ 14,570 per person, accounting for 17.6% of the nation's Gross Domestic Product.

Hence, the rising healthcare costs necessitate cost-effective solutions for patient monitoring and outcomes. Disposable medical sensors offer real-time monitoring for various conditions, enabling continuous tracking of vital signs, chronic disease management, and early detection, potentially reducing hospital readmissions and emergency care costs. This trend is expected to accelerate the disposable medical sensors market growth.

Europe is growing at the fastest pace in the Disposable Medical Sensors market

Europe holds the fastest pace in the disposable medical sensors market and is expected to hold most of the market share due to robust healthcare systems, government investments, and favourable reimbursement policies are encouraging the integration of disposable sensors for preventive care and chronic disease management. The adoption of wearable and remote patient monitoring devices is growing due to the convenience and cost-effectiveness of these devices. The strong regulatory framework in Europe ensures then safety and efficacy of medical devices, fostering trust in disposable medical sensors.

For instance, in May 2024, Dexcom has launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK, using Dexcom's established sensor design and user feedback. The platform is designed for people treating type 1 or type 2 diabetes with insulin, using the latest-generation G7 sensor. The CGM is expected to be completed in Q1 2024. The system also adds notes at specific moments, such as meals, insulin administration, and sports activities, replacing traditional fingersticks to provide a clear picture of how daily choices affect glucose levels.

Competitive Landscape

The major global players in the disposable medical sensors market include Medtronic Plc, Honeywell International, Inc, GE Healthcare, Koninklijke Philips N.V, Sensirion AG, Analog Devices, Inc, Gentag Inc, Smiths Medical, ACE Medical Devices, Abbott Laboratories and among others.

Key Developments

In December 2023, Infineon Technologies AG has introduced its CoolMOS S7T product family, featuring an integrated temperature sensor, which enhances junction temperature sensing accuracy. This enhances the durability, safety, and efficiency of electronic applications, particularly in solid-state relay (SSR) applications, due to its superior RDS and highly accurate sensor.
In May 2023, Philips introduces a next-generation wearable biosensor for clinical COVID-19 surveillance and early patient deterioration identification, a five-day disposable patch linked to a scalable hub for monitoring multiple patients in different rooms.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global disposable medical sensors market report delivers a detailed analysis with 70+ key tables, more than 65 visually impactful figures, and 234 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Sensor Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Limited Regulatory Approvals and Standards
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Biosensors*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Accelerometers
6.4. Temperature Sensors
6.5. Image Sensors
6.6. Pressure Sensors
6.7. Others

7. By Sensor Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
- 7.1.2. Market Attractiveness Index, By Sensor Type
7.2. Implantable Sensors *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Strip Sensors
7.4. Wearable Sensors

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Patient Monitoring*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Imaging
8.4. Therapeutics
8.5. Fitness and Wellness Monitoring
8.6. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic Centers
9.4. Home Healthcare
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

12.1. Medtronic Plc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. Honeywell International, Inc
12.3. GE Healthcare
12.4. Koninklijke Philips N.V
12.5. Sensirion AG
12.6. Analog Devices, Inc
12.7. Gentag Inc
12.8. Smiths Medical
12.9. ACE Medical Devices
12.10. Abbott Laboratories
Similar data will be provided for each market player.

Emerging Market Players

12.11. Nemaura Medical *
- 12.11.1. Pipeline Products Description
- 12.11.2. Product Key Performance Indicators (KPIs)
- 12.11.3. Key Activities
- 12.11.4. Market Entry Timelines
- 12.11.5. Product Penetration Rate
- 12.11.6. Sales Estimation and Projections
12.12. DiaMonTech AG
12.13. BioXensor
12.14. GlucoModicum
12.15. KnowLabs
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE